pembrolizumab

Janice Ser Huey Tan1, Timothy Kwang Yong Tay2, Enya Hui Wen Ong3

  • 1J Tan, Radiation Oncology, National Cancer Centre Singapore, Singapore, Singapore.

European thyroid journal
|January 5, 2024
PubMed
概括

这项研究探讨了将免疫疗法 (pembrolizumab) 与辐射疗法 (QUAD-shot RT) 结合起来,用于治疗无塑性甲状腺癌 (ATC). 治疗显示出有希望的反应率,并且耐受性良好,这表明ATC患者的长期存活潜力.

相关概念视频

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K